Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines

NCT04705389 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT04705389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04705389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines
Lead sponsor
University Hospital, Tours
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 5, 2022
Completion date
December 31, 2026
Enrollment
35 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

merkel cell carcinoma